Area of research
Economics and Econometrics · Orthopedics and Sports Medicine
Research interest
Research interests include Health Systems, Economic Evaluations, Quality of Life, Bone health and osteoporosis research, Venous Thromboembolism Diagnosis and Management, and Academic Writing and Publishing.
Caring for and Caring about in Economic Evaluation: Modelling the Family and Caregiving Effects.
Model-based economic evaluation of non-pharmacological interventions for fatigue in patients with long-term medical conditions in the UK.
Effectiveness of non-pharmacological interventions for fatigue in long term conditions: systematic review and network meta-analysis.
An Attribution of Value Framework for Combination Treatments.
Effectiveness of non-pharmacological Interventions For Fatigue in Long term conditions (EIFFEL)-systematic review and network meta-analysis
What influences women's decisions to participate in trials for prevention of venous thromboembolism during pregnancy and the puerperium: a qualitative study.
Economic evaluation of non-pharmacological interventions for fatigue in patients with long-term medical conditions
Cost effectiveness of non-pharmacological interventions for fatigue in patients with long-term conditions: a systematic literature review.
Methodological and Procedural Considerations for Developing Decision Analytic Models to Assess the Health Economic Impacts of Newborn Bloodspot Screening: A Systematic Methodological Review.
Effectiveness and cost effectiveness of pharmacological thromboprophylaxis for medical inpatients: decision analysis modelling study.
Estimating the value of future research into thromboprophylaxis for women during pregnancy and after delivery: a value of information analysis.
The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis.
Evaluation of venous thromboembolism risk assessment models for hospital inpatients: the VTEAM evidence synthesis.
An online clinical decision tool to screen for vertebral fragility fractures (Vfrac) in older women presenting with back pain in general practice: protocol for a feasibility study in preparation for a future cluster randomised controlled trial.
Thromboprophylaxis during pregnancy and the puerperium: a systematic review and economic evaluation to estimate the value of future research.
Bisphosphonate alternative regimens for the prevention of osteoporotic fragility fractures: BLAST-OFF, a mixed-methods study.
What influences women’s decisions to participate in trials for prevention of venous thromboembolism during pregnancy and the puerperium: a qualitative study
Decision-analysis modeling of effectiveness and cost-effectiveness of pharmacologic thromboprophylaxis for surgical inpatients using variable risk assessment models or other strategies.
Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise.
Risk assessment models for venous thromboembolism in pregnancy and in the puerperium: a systematic review.
A clinical tool to identify older women with back pain at high risk of osteoporotic vertebral fractures (Vfrac): a population-based cohort study with exploratory economic evaluation.
Assessing the Effectiveness of Bisphosphonates for the Prevention of Fragility Fractures: An Updated Systematic Review and Network Meta-Analyses.
Comparing medication adherence in patients receiving bisphosphonates for preventing fragility fractures: a comprehensive systematic review and network meta-analysis.
Utility of PINP to monitor osteoporosis treatment in primary care, the POSE study (PINP and Osteoporosis in Sheffield Evaluation).
Which is the best model to assess risk for venous thromboembolism in hospitalised patients?
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Poster Abstracts
2021cited by 0position: contributor
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation
Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: A systematic review and network meta-analysis.
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.